Citius Announces Pre-IND Submission to FDA Under the Coronavirus Treatment Acceleration Program for a Novel Stem Cell Therapy for Acute Respiratory Distress Syndrome (ARDS) in COVID-19 Apr 27, 2020
Citius Signs Exclusive Option with Novellus to License Novel Stem-Cell Therapy for Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19 Apr 1, 2020
Citius Pharmaceuticals Announces Publication in Antimicrobial Agents and Chemotherapy Journal of Positive Preclinical Results for Mino-Lok® in Rapidly Eradicating Candida Auris Mar 26, 2020
Citius Pharmaceuticals Cites Independent Estimates of Total Available World Market for Mino-Lok® Feb 25, 2020
Citius Pharmaceuticals to Present at Noble Capital Markets' 16th Annual Investor Conference Feb 10, 2020
Citius Announces Positive Outcome of Interim Futility Analysis for its Phase 3 Mino-Lok® Pivotal Trial Dec 19, 2019
